Navigation Links
ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
Date:8/23/2007

Protocols on ImmuneRegen's Homspera(TM) Submitted to RFI, 'Therapeutic

Countermeasures against CDC Category A and B Threat Agents'

SCOTTSDALE, Ariz., Aug. 23 /PRNewswire-FirstCall/ -- Research and development biotechnology company ImmuneRegen BioSciences, Inc. a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBO.OB), announced today that it has recently responded to a Request for Information (RFI) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense for Therapeutic Countermeasures against CDC Category A and B Threat Agents. ImmuneRegen made its submission August 20, 2007 with information on its potential treatment, Homspera(TM).

ImmuneRegen filed a formal response to the RFI respective to its compound Homspera(TM), currently in development as a therapeutic and prophylactic countermeasure against multiple pathogens including multiple biological, chemical and radiological threats. For the purposes of this request, the RFI submission focuses primarily on anthrax countermeasures.

"We believe that Homspera is at the forefront of the development of Category A and B countermeasures," commented Michael Wilhelm, co-founder and CEO of ImmuneRegen. "Our studies have shown Homspera to be effective in protecting experimental animals against the lethal effects of ionizing radiation, infection with anthrax spores, infection with influenza virus, and to be an adjuvant in influenza vaccine studies. We believe Homspera's mode of action includes an immunostimulatory activity that results in enhanced host defenses against multiple pathogens."

Should this RFI lead to further studies, ImmuneRegen expects to partner with appropriate governmental agencies, such as USAMRIID (U.S. Army Medical Research Institute for Infectious Diseases) or AFIP (Armed Forces Institute of Pathology).

About Homspera(TM)

Homspera is a generic name used by the Company to describe the synthetic peptide Sar
'/>"/>

SOURCE ImmuneRegen BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Third Wave responds to Digene patent lawsuit
2. Epic responds to critics of electronic record installation
3. Small Tree Communications awarded $2.85M defense contract
4. Research consortium aims to bring security and defense contracts to Wisconsin
5. MATC student team wins cyber defense contest
6. National Bio and Agro Defense fits Wisconsin
7. Chippewa Valley firms land more defense work
8. Wisconsins failure to attract federal defense dollars crimps tech economy
9. Defense contract helps Plexus gain record profits
10. Chippewa Valley to get $46 million in defense spending
11. Wisconsins untapped defense might: why saving military bases is just a start
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused ... analysis of tumor cells in the bloodstream, today announced ... decision support application powered by CollabRx, Inc. , ... test, Therapy Finder will provide breast cancer patients and ...
(Date:1/15/2014)... Houston, TX (PRWEB) January 15, 2014 ... Alzheimer’s disease, and about 1 in 3 seniors will ... ( source ). These jaw-dropping figures have shocked many ... function and, hopefully, help prevent these tragic age-related cognitive ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider ... Limited, one of India’s top five pharmaceutical companies, has ... for high throughput solid form screening. , ... wide range of quality, affordable generic and branded formulations ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... , , , E-mail us your application notes for inclusion in this ... of electroporation , cuvettes. , , , ... , Bacteria, gram negative , , ... href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus , ...
... , , , , , ... Katherine A. Borkovich PhD, University of Texas-Houston Medical Center, , ... Texas. , Kimberly Vollmer, Brinkmann™ Instruments Inc., BioSystems Application ... , , , , ...
... , , , , , ... , regulatory promoter and enhancer sequences as well ... element under investigation (promoter, enhancer) is cloned , ... used to transfect cells. Quantification of the reporter ...
Cached Biology Technology:Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 2Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 3Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 4Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 5Efficient Transfection of Neurospora Crassa 2Efficient Transfection of Neurospora Crassa 3Efficient Transfection of Neurospora Crassa 4Efficient Transfection of Neurospora Crassa 5Genetic Reporter Systems 2Genetic Reporter Systems 3Genetic Reporter Systems 4
(Date:4/18/2014)... as soon as they,re planted may be good news for ... In the wild, a plant whose seeds sprouted at the ... than just an insurance policy against late frosts or unexpected ... advantages too: Plants whose seeds put off sprouting until ... in a team of researchers working at the National Evolutionary ...
(Date:4/17/2014)... peptide inhibits RSV infection , Respiratory syncytial ... respiratory tract infections, generating life-threating illness in very ... therapies are limited. RSV enters host cells through ... six-helix fusogenic bundle. Small interfering peptides that prevent ... these peptides are highly susceptible to degradation. In ...
(Date:4/17/2014)... Professor Luca Razzari of the nergie Matriaux Tlcommunications ... from the John R. Evans Leaders Fund of ... acquisition of state-of-the-art biotech and nanophotonics equipment. To ... the Ministre de l,Enseignement suprieur, de la Recherche, ... These new laboratories will help us develop new ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
... to a virulent family of bacteria called Yersinia, a ... poisoning. These bacteria insert into their host cells proteins ... other things -- disrupting the cells' normal structure. One ... skeleton. Now, a study published by Rockefeller University researchers ...
... announced today that researchers at the Translational Genomics ... the Affymetrix 500K Array to discover a gene--called ... findings may be used to develop new medicines ... by providing scientists with a better understanding of ...
... birth weights tend to have a much lower quality of life ... study published in the latest issue of the UK-based Journal of ... weights of 1500g or less and compared them with a control ... of life when it came to physical, emotional, cognitive and social ...
Cached Biology News:A wolf in sheep's clothing: Plague bacteria reveal one of their virulence tricks 2Affymetrix 500K array used to identify memory gene 2Very low birth weight linked to reduced quality of life in pre-school children 2
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... the blending of thermostable DNA polymerases with ... Template PCR Systems, now introduces the Expand ... product of a family of next-generation PCR ... DNA Polymerase with a novel proofreading protein ...
... Source: Escherichia coli RY 13 5'G AATTC3' ... for 15 min or ethanol precipitation. Storage Conditions: ... 1.0mM DTT, 0.15% Triton X-100, 0.01% BSA, 50% ... Store at -20C. Unit Definition: One unit is ...
Biology Products: